Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology

Bryony C Gray1, Zuzana Siskova, V Hugh Perry

  • 1School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton, Hants, UK.

Insights

Prion disease models show early loss of presynaptic proteins and synapses in the hippocampus. This "synaptopathy" may be the first sign of neuronal dysfunction in neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Prion Disease Research
  • Neurodegeneration

Background:

  • Prion diseases are characterized by misfolded prion protein (PrPSc) accumulation.
  • The ME7 strain in mice provides a model for studying prion disease progression.
  • Early neuronal dysfunction in prion diseases remains incompletely understood.

Purpose of the Study:

  • To investigate early synaptic changes in a mouse model of prion disease.
  • To determine the relationship between PrPSc accumulation and presynaptic alterations.
  • To identify potential earliest markers of neuronal dysfunction.

Main Methods:

  • Intrahippocampal injection of ME7 prion homogenate in mice.
  • Biochemical analysis of presynaptic protein expression at 8, 12, and 21 weeks.
  • Electron microscopy to assess synaptic morphology and density.
  • Evaluation of postsynaptic changes in relation to presynaptic integrity.

Main Results:

  • Misfolded prion protein (PrPSc) accumulation correlated with reduced presynaptic protein expression.
  • Synapse numbers progressively decreased in the stratum radiatum.
  • An increase in postsynaptic specializations without intact presynaptic partners was observed.
  • Presynaptic compartment disruption occurred independently of CA3 neuron cell body loss.

Conclusions:

  • Selective presynaptic pathology, termed "synaptopathy," occurs early in ME7 prion disease.
  • This synaptopathy may represent the initial neuronal dysfunction in prion and other protein misfolding neurodegenerative diseases.
  • Early synaptic disruption precedes significant cell body loss, highlighting its role in disease pathogenesis.

Related Concept Videos

Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...